within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DE03_Cefozopran;

model Cefozopran
  extends Pharmacolibrary.Drugs.ATC.J.J01DE03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01DE03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefozopran is a fourth-generation cephalosporin antibiotic used primarily in Japan for the treatment of a broad spectrum of bacterial infections, including respiratory tract, urinary tract, skin, and intra-abdominal infections. It is administered mainly in hospital settings and is not currently approved in the US or EU.</p><h4>Pharmacokinetics</h4><p>Healthy adult subjects after single intravenous administration.</p><h4>References</h4><ol><li><p>Wu, GL, et al., &amp; Wu, LH (2015). Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteers. <i>Drugs in R&amp;D</i> 15(1) 63–70. DOI:<a href=\"https://doi.org/10.1007/s40268-014-0075-3\">10.1007/s40268-014-0075-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25644122/\">https://pubmed.ncbi.nlm.nih.gov/25644122</a></p></li><li><p>Ikawa, K, et al., &amp; Sueda, T (2007). Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients. <i>International journal of antimicrobial agents</i> 30(4) 352–355. DOI:<a href=\"https://doi.org/10.1016/j.ijantimicag.2007.06.001\">10.1016/j.ijantimicag.2007.06.001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17644344/\">https://pubmed.ncbi.nlm.nih.gov/17644344</a></p></li><li><p>Guo, WW, et al., &amp; Liang, MZ (2012). [Pharmacokinetics of injected cefozopran hydrochloride in healthy volunteers]. <i>Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition</i> 43(5) 711–714. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23230745/\">https://pubmed.ncbi.nlm.nih.gov/23230745</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Cefozopran;
